BNP Paribas Financial Markets’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $112K | Buy |
|
|||||
|
2025
Q2 | $35.4K | Sell |
|
|||||
|
2025
Q1 | $555K | Sell |
|
|||||
|
2024
Q4 | $520K | Buy |
|
|||||
|
2024
Q3 | $340K | Buy |
|
|||||
|
2024
Q2 | $13.3K | Sell |
|
|||||
|
2024
Q1 | $374K | Buy |
|
|||||
|
2023
Q4 | $295K | Buy |
|
|||||
|
2023
Q3 | $192K | Buy |
|
|||||
|
2023
Q2 | $59.2K | Sell |
|
|||||
|
2023
Q1 | $91.4K | Sell |
|
|||||
|
2022
Q4 | $151K | Buy |
|
|||||
|
2022
Q3 | $113K | Buy |
|
|||||
|
2022
Q2 | $40.7K | Buy |
|
|||||
|
2022
Q1 | $41.7K | Sell |
|
|||||
|
2021
Q4 | $91.5K | Buy |
|
|||||
|
2021
Q3 | $110K | Buy |
|
|||||
|
2021
Q2 | $28.1K | Sell |
|
|||||
|
2021
Q1 | $135K | Buy |
|
|||||
|
2020
Q4 | $72.2K | Sell |
|
|||||
|
2020
Q3 | $101K | Buy |
|
|||||
|
2020
Q2 | $10.8K | Sell |
|
|||||
|
2020
Q1 | $80.7K | Buy |
|
|||||
|
2019
Q4 | $41.4K | Sell |
|
|||||
|
2019
Q3 | $50K | Buy |
|
|||||
|
2019
Q2 | $48.4K | Sell |
|
|||||
|
2019
Q1 | $89.8K | Buy |
|
|||||
|
2018
Q4 | $9.12K | Sell |
|
|||||
|
2018
Q3 | $28.1K | Hold |
|
|||||
|
2018
Q2 | $24.8K | Sell |
|
|||||
|
2018
Q1 | $108K | Buy |
|
|||||
|
2017
Q4 | $117K | Buy |
|
|||||
|
2017
Q3 | $24K | Sell |
|
|||||
|
2017
Q2 | $33.2K | Buy |
|
|||||
|
2017
Q1 | $14.5K | Buy |
|
|||||
|
2016
Q4 | $3.84K | Sell |
|
|||||
|
2016
Q3 | $23.9K | Buy |
|
|||||
|
2016
Q2 | $8.06K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $51.2K | Sell |
|
|||||
|
2015
Q3 | $46.4K | Buy |
|
|||||
|
2015
Q2 | $23.5K | Buy |
|
|||||
|
2015
Q1 | $7.39K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $10.1K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $3.22K | Sell |
|
|||||
|
2013
Q3 | $85.2K | Sell |
|
|||||
|
2013
Q2 | $96.7K | Buy |
|